These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19686846)

  • 1. Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance.
    Van Eerdenbrugh B; Van Speybroeck M; Mols R; Houthoofd K; Martens JA; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G
    Eur J Pharm Sci; 2009 Oct; 38(3):270-8. PubMed ID: 19686846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study.
    Janssens S; Nagels S; Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
    Eur J Pharm Biopharm; 2008 May; 69(1):158-66. PubMed ID: 18164929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
    Moneghini M; De Zordi N; Solinas D; Macchiavelli S; Princivalle F
    Future Med Chem; 2010 Feb; 2(2):237-46. PubMed ID: 21426191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of spray drying, electroblowing and electrospinning for preparation of Eudragit E and itraconazole solid dispersions.
    Sóti PL; Bocz K; Pataki H; Eke Z; Farkas A; Verreck G; Kiss É; Fekete P; Vigh T; Wagner I; Nagy ZK; Marosi G
    Int J Pharm; 2015 Oct; 494(1):23-30. PubMed ID: 26241751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
    Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
    Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs.
    Van den Mooter G; Weuts I; De Ridder T; Blaton N
    Int J Pharm; 2006 Jun; 316(1-2):1-6. PubMed ID: 16563676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state.
    Weerapol Y; Limmatvapirat S; Jansakul C; Takeuchi H; Sriamornsak P
    Eur J Pharm Biopharm; 2015 Apr; 91():25-34. PubMed ID: 25615879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.
    Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM
    Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Compression on the Molecular Arrangement of Itraconazole-Soluplus Solid Dispersions: Induction of Liquid Crystals or Exacerbation of Phase Separation?
    Singh A; Bharati A; Frederiks P; Verkinderen O; Goderis B; Cardinaels R; Moldenaers P; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2016 Jun; 13(6):1879-93. PubMed ID: 27092396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole.
    Kumar S; Shen J; Burgess DJ
    J Control Release; 2014 Oct; 192():95-102. PubMed ID: 25009979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
    Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
    Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a new hydrophilic polymer, Kollicoat IR, in the formulation of solid dispersions of Itraconazole.
    Janssens S; de Armas HN; Remon JP; Van den Mooter G
    Eur J Pharm Sci; 2007 Mar; 30(3-4):288-94. PubMed ID: 17204410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray drying from complex solvent systems broadens the applicability of Kollicoat IR as a carrier in the formulation of solid dispersions.
    Janssens S; Anné M; Rombaut P; Van den Mooter G
    Eur J Pharm Sci; 2009 Jun; 37(3-4):241-8. PubMed ID: 19491011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
    Dhumal RS; Biradar SV; Aher S; Paradkar AR
    J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
    Lang B; Liu S; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2016; 42(3):429-45. PubMed ID: 26355819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
    Goddeeris C; Van den Mooter G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.